Clinical trial software should be used to instill confidence in potential participants during the earliest stages of enrollment. Ensuring potential participants during eConsent and eQualification will not only accelerate enrollment, but also improve retention.
Clinical trial software has the ability to provide personalized educational resources and a comprehensive platform for the study that demonstrates transparency, consistency, privacy, and confidentiality to the potential participant.
Personalized Educational Resources
A strength of clinical trial software is its dynamic ability to educate. The patient is provided with more than just pages of information to review. Interactive learning materials are readily available for the potential participant to learn about the trial and understand the requirements and qualifications.
For instance, the Clinical Reach platform provides four levels of verification to ensure absolute clarity of the trial:
- Clinical Coordinator Interviews
The Comprehensive Platform
Clinical trial software can create the information from the patient, as opposed to the information coming from the provider, but the extensive data collection must be housed in a comprehensive platform in order to ensure the patient with the highest levels of control, consistency, and transparency.
Consistent communication, documentation, and branding within the platform provides stakeholders with less room for error. Real-time data generated by the clinical trial software provides the ability to track the patient’s progress at any point in the study, resulting in the most efficient communication between provider and patient. At any time, the PI or Clinical Coordinator can access the status of a patient’s enrollment through the Clinical Reach backend platform. The information is readily available at the patient’s request, providing transparency and confidence in the trial.
Confirmation of Privacy and Confidentiality
Reiteration of compliance with privacy protocol is especially important in the early stages of eConsent and eQualification for a clinical trial. Legal and ethical protection rights should be clearly explained and identifiable by the potential participant. Graphic references are also helpful to provide confidence that the process is safe and secure.
Potential clinical trial participants who feel ensured during the eQualification and eConsent process are less likely to experience confusion or skepticism and will be more likely to remain as a participant for the entire study.
Parallel 6 has developed the mobile enterprise platform Clinical Reach that creates a seamless and virtually effortless process to educate patients and ensure confidence in a trial. If you would like to learn more about how the Clinical Reach platform works, please visit Parallel 6’s website and request a demo.